Abstract
The ability of endothelial progenitor cells (EPCs) to participate in endothelial repair is impaired by angiotensin II (Ang II) and other atherogenic factors. Therefore, we investigated the effects of Ang II on the differentiation and senescence of EPCs derived from bone marrow (BM-EPCs) in an Ang II–infusion rat model. Wistar rats (n=40) were infused with Ang II or vehicle, either alone or in combination with an Ang II type 1 receptor (AT1R) blocker (valsartan). Bone marrow cells were obtained from the tibias and femurs. Rats of the Ang II treatment group had a significantly lower number of differentiated, adherent BM-EPCs than those of the non-treated control group. Addition of valsartan restored the level of attached, differentiated BM-EPCs to the level in the non-treated controls. The number of senescent BM-EPCs, as assessed by acidic β-galactosidase staining, was significantly greater in the Ang II–alone group than the control group, and addition of valsartan dramatically delayed the senescence of BM-EPCs in the Ang II–alone group. A polymerase chain reaction (PCR)-ELISA–based assay revealed that telomerase activity was significantly lower in BM-EPCs from the Ang II–alone group than in those from the control group, and addition of valsartan significantly augmented this activity. An MTS assay revealed that Ang II treatment significantly decreased the functional activity in BM-EPCs, and this effect was significantly reversed by valsartan. In conclusion, Ang II decreased the differentiation and accelerated the senescence of BM-EPCs via AT1R.
Similar content being viewed by others
Article PDF
References
Asahara T, Murohara T, Sullivan M, et al: Isolation of putative progenitor endothelial cells to angiogenesis. Science 1997; 275: 964–967.
Shi Q, Rafii S, Wu MH, et al: Evidence for circulating bone marrow–derived endothelial cells. Blood 1998; 92: 362–367.
Kong D, Melo LG, Mangi AA, et al: Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004; 109: 1769–1775.
Iwakura A, Luedemann C, Shastry S, et al: Estrogen-mediated, endothelial nitric oxide synthase–dependent mobilization of bone marrow–derived endothelial progenitor cells contributes to reendotheliazation after arterial injury. Circulation 2004; 108: 3115–3121.
Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593–600.
Vasa M, Fichtlscherer S, Aicher A, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: e1–e7.
Min TQ, Zhu CJ, Xiag WX, Hui ZJ, Peng SY : Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary disease. Cardiovasc Drugs Ther 2004; 18: 203–209.
Imanishi T, Hano T, Nishio I : Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005; 23: 97–104.
Bunag RD : Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 1973; 34: 279–282.
Imanishi T, Hano T, Sawamura T, Nishio I : Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 2004; 31: 407–413.
Kawamoto A, Gwon HC, Iwaguro H, et al: Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634–637.
Assmus B, Schachinger V, Teupe C, et al: Transplatation of Progenitor Cell and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009–3017.
Tepper OM, Galiano RD, Capla JM, et al: Human endothelial progenitor cells from type II diabetes exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781–2786.
Imanishi T, Hano T, Nishio I : Angiotensin II potentiates vascular endothelial growth factor–induced proliferation and network formation of endothelial progenitor cells. Hypertens Res 2004; 27: 101–108.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kobayashi, K., Imanishi, T. & Akasaka, T. Endothelial Progenitor Cell Differentiation and Senescence in an Angiotensin II-Infusion Rat Model. Hypertens Res 29, 449–455 (2006). https://doi.org/10.1291/hypres.29.449
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.449
Keywords
This article is cited by
-
Hypertension and cellular senescence
Biogerontology (2023)
-
ERK signaling is required for VEGF-A/VEGFR2-induced differentiation of porcine adipose-derived mesenchymal stem cells into endothelial cells
Stem Cell Research & Therapy (2017)